So, the fact that we saw only a 10% recurrence rate in our study is incredibly promising." Cryoablation is a minimally invasive treatment that uses imaging guidance such as ultrasound or computed ...

Adagio will now put its resources toward completing the pivotal U.S. trial of its vCLAS catheter and its subsequent marketing ...

IceCure Medical’s cryoablation technology ProSense has demonstrated it can reduce breast cancer tumour sizes by 100% after 12 months, in an independent study. The 39-patient cohort was monitored ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

Cryoablation was performed using contemporary technology (TRUS [transrectal ultrasound] guidance with argon/helium third-generation equipment), and the study protocol allowed the procedure to be ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual ...

As a result of this shift, Adagio said its restructuring includes a reduction in workforce, effective today, Feb. 28. The company did not disclose how many employees are included in the reduction. It ...

“Our resources are now focused on the completion of the FULCRUM-VT Pivotal IDE trial and subsequent premarket approval of the VT Cryoablation System with vCLAS™ catheter from the U.S. Food and Drug ...

Adagio Medical (ADGM) announced a corporate restructuring and realignment of resources to prioritize its FULCRUM-VT US pivotal investigational ...

Application covering a wide range of indications is in line with trends in de-escalation of surgery and growth in minimally invasive cryoablation procedures, pointing to strong potential for ...